Zobrazeno 1 - 10
of 52
pro vyhledávání: '"C. Study Group"'
Publikováno v:
European Psychiatry, Vol 66, Pp S64-S65 (2023)
Introduction The traditional Patient Health Questionnaire (PHQ-9) cut-off score of ≥10 has been found to balance best sensitivity and specificity when used in patient populations. Depression screening has been recommended in general population surv
Externí odkaz:
https://doaj.org/article/422ca7714c8c48f18fb7361e2a57c915
Autor:
S. Awasthi, C. Mani Pandey, T. Verma, N. Mishra, R. Chandra Shukla, N. Mohindra, A. Chauhan, M. Agarwal, N. Kohli, C. Study Group
Publikováno v:
International Journal of Infectious Diseases, Vol 101, Iss , Pp 157- (2020)
Externí odkaz:
https://doaj.org/article/ae0daafaca9a4543a4281fc3d566074d
Autor:
MOSAIC (MSM Observational Study for Acute Infection with hepatitis C) Study Group, Vanhommerig, Joost W., Thomas, Xiomara V., van der Meer, Jan T. M., Geskus, Ronald B., Bruisten, Sylvia M., Molenkamp, Richard, Prins, Maria, Schinkel, Janke
Publikováno v:
Clinical Infectious Diseases, 2014 Dec . 59(12), 1678-1685.
Externí odkaz:
https://www.jstor.org/stable/26362576
Autor:
Benhur Sirvan, Cetin, Ayşenur Paç, Kısaarslan, Sedanur, Tekin, Merve Basol, Goksuluk, Ali, Baykan, Başak Nur, Akyıldız, Yılmaz, Seçilmiş, Hakan, Poyrazoglu, On Behalf Of The Erciyes Mis-C Study Group
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 15; Pages: 4615
Background: Two years after the first cases, critical gaps remain in identifying prognostic factors in multisystem inflammatory syndrome in children (MIS-C). Methods: This retrospective study included 99 patients with MIS-C hospitalized between Augus
Publikováno v:
Harm Reduction Journal, Vol 18, Iss 1, Pp 1-10 (2021)
Harm Reduction Journal
Harm Reduction Journal
Background With direct-acting antivirals dramatically reshaping the public health response to the hepatitis C virus (HCV), prisons are set to play a critical role in elimination efforts. Despite the theoretical demonstration of HCV treatment-as-preve
Autor:
Graham R Foster, Carmine Coppola, Moutaz Derbala, Peter Ferenci, Alessandra Orlandini, K Rajender Reddy, Ludovico Tallarico, Mitchell L Shiffman, Silke Ahlers, Georgios Bakalos, Tarek Hassanein, GUARD-C Study Group
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0151703 (2016)
Despite the introduction of direct-acting antiviral agents for chronic hepatitis C virus (HCV) infection, peginterferon alfa/ribavirin remains relevant in many resource-constrained settings. The non-randomized GUARD-C cohort investigated baseline pre
Externí odkaz:
https://doaj.org/article/3320dc0aafb54ec984e74a88f0ea58b4
Autor:
Bagri, Narendra Kumar, Khan, M., Pandey, R. M., Lodha, Rakesh, Kabra, S. K., MIS-C study group, Angurana, Suresh Kumar, Awasthi, Shally, Bamnawat, Harshita, Bhat, Javeed Iqbal, Bhutia, Tsultem D., Charoo, Bashir Ahmad, Choudhary, Abhijit, Choudhary, Bharat, Das, Rashmi Ranjan, Dwibedi, Bhagirathi, Ghosh, Sanajit, Girish, Meenakshi, Gulla, Krishna Mohan, Goyal, Jagdish Prasad
Publikováno v:
Indian Journal of Pediatrics; Dec2022, Vol. 89 Issue 12, p1236-1242, 7p
Autor:
Banipal, G. S., Stimec, B. V., Andersen, S. N., Faerden, A. E., Edwin, B., Baral, J., Nesgaard, J. M., Benth, J. Šaltytė, Ignjatovic, D., For the R. C. C. study group, Oresland, Tom, Bakka, Arne O., Thorsen, Yngve, Negaard, Anne, Jacobsen, Russel, von Brandis, Kari Mette Langerød, Hansen, Tania, Suhrke, Pål, Luzon, Javier, Sevinç, Barış
Publikováno v:
Journal of Gastrointestinal Surgery; Oct2022, Vol. 26 Issue 10, p2201-2211, 11p
Autor:
Daphne C Wu, Prabhat Jha, Teresa Lam, Patrick Brown, Hellen Gelband, Nico Nagelkerke, H Chaim Birnboim, Angus Reid, Action to Beat Coronavirus in Canada/Action pour Battre le Coronavirus (Ab-C) Study Group
Publikováno v:
PLoS ONE, Vol 15, Iss 10, p e0240778 (2020)
PLoS ONE
PLoS ONE
Random population-based surveys to estimate prevalence of SARS-CoV2 infection causing coronavirus disease (COVID-19) are useful to understand distributions and predictors of the infection. In April 2020, the first-ever nationally representative surve
Autor:
Maureen J Donlin, Nathan A Cannon, Rajeev Aurora, Jia Li, Abdus S Wahed, Adrian M Di Bisceglie, John E Tavis, Virahep-C Study Group
Publikováno v:
PLoS ONE, Vol 5, Iss 2, p e9032 (2010)
Hepatitis C virus (HCV) has six major genotypes, and patients infected with genotype 1 respond less well to interferon-based therapy than other genotypes. African American patients respond to interferon alpha-based therapy at about half the rate of C
Externí odkaz:
https://doaj.org/article/322a69d3dcbe432fa8cf4f8e2b489b0e